Metraipolis › archive › dc_786ed7dce903

Nanobody-Engineered CLL-1 CAR T Cells: Optimizing Tumor-Specific Cytotoxicity and Minimizing Off-Tumor Toxicity — Europe PMC PMID:41721623

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41721623
DOI
10.1158/2767-9764.crc-25-0521
License (as archived)
solo-consultazione
Archived
2026-11-05T11:17:23.242Z
SHA-256 of the archived text
36eb7158768c8fd1ab35caff96a245355ba760ec8ea76fde5d03f3b4eeaf0d1d
Stable URL of this page
https://metraipolis.com/documento/dc_786ed7dce903

How to cite

Nanobody-Engineered CLL-1 CAR T Cells: Optimizing Tumor-Specific Cytotoxicity and Minimizing Off-Tumor Toxicity — Europe PMC PMID:41721623 — Europe PMC (en), https://europepmc.org/article/MED/41721623 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_786ed7dce903 (Metraipolis archive dc_786ed7dce903, sha256 36eb7158768c8fd1ab35caff96a245355ba760ec8ea76fde5d03f3b4eeaf0d1d)
BibTeX
@misc{dc786ed7dce903,
  title = {Nanobody-Engineered CLL-1 CAR T Cells: Optimizing Tumor-Specific Cytotoxicity and Minimizing Off-Tumor Toxicity — Europe PMC PMID:41721623},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41721623},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_786ed7dce903; sha256 36eb7158768c8fd1ab35caff96a245355ba760ec8ea76fde5d03f3b4eeaf0d1d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41721623. Agents can read the archived copy with the MCP tool read_document.